1 00:00:04,585 --> 00:00:07,745 Intro and Outro: Hello, and welcome to the Microbiome Medics Podcast. 2 00:00:07,925 --> 00:00:12,545 Intro and Outro: I'm Dr. Siobhan McCormack. And I'm Dr. Sheena Fraser, and we're your co-hosts. 3 00:00:12,705 --> 00:00:17,425 Intro and Outro: We are both GPs and lifestyle medics with a shared passion for microbiome science. 4 00:00:17,605 --> 00:00:21,245 Intro and Outro: We'll be translating the evidence and packaging it into actionable, 5 00:00:21,565 --> 00:00:25,865 Intro and Outro: bite-sized chunks so that you could harness the power of the microbiome to improve 6 00:00:25,865 --> 00:00:28,045 Intro and Outro: your own health and that of your patients. 7 00:00:31,005 --> 00:00:34,665 Sheena Fraser: Hello, and welcome to another Microbiomedics podcast. I'm Dr. 8 00:00:34,805 --> 00:00:37,865 Sheena Fraser: Sheena Fraser, and today I'm joined with Dr. Michael Cox. 9 00:00:38,225 --> 00:00:41,965 Sheena Fraser: Dr. Michael Cox is going to introduce us to the lung microbiome today. 10 00:00:41,965 --> 00:00:47,625 Sheena Fraser: So we've already had a little intro into the vaginal microbiome, the skin microbiome. 11 00:00:47,705 --> 00:00:50,665 Sheena Fraser: We've obviously touched a lot on the gut microbiome. 12 00:00:50,865 --> 00:00:53,985 Sheena Fraser: So today I'm really excited to delve into the lung microbiome. 13 00:00:54,225 --> 00:01:01,525 Sheena Fraser: Dr. Cox is based in Birmingham, and his research focuses on microbial ecology 14 00:01:01,525 --> 00:01:04,005 Sheena Fraser: of the respiratory tract. 15 00:01:04,205 --> 00:01:10,845 Sheena Fraser: And he's translating the microbial analysis of the respiratory tract into clinical, 16 00:01:11,185 --> 00:01:14,605 Sheena Fraser: useful, knowledgeable information for our clinicians. 17 00:01:15,045 --> 00:01:18,485 Sheena Fraser: So today, let's have a little chat. 18 00:01:18,625 --> 00:01:22,525 Sheena Fraser: We're going to touch on what the lung microbiome is. We're going to take you 19 00:01:22,525 --> 00:01:27,785 Sheena Fraser: through the importance and the correlation between the lung microbiome and the 20 00:01:27,785 --> 00:01:30,985 Sheena Fraser: gut microbiome, and also the communication between the two, 21 00:01:31,145 --> 00:01:34,365 Sheena Fraser: and then translation into the clinical side, 22 00:01:34,545 --> 00:01:37,925 Sheena Fraser: you know, how this impacts on our health, how it impacts on disease, 23 00:01:38,165 --> 00:01:41,905 Sheena Fraser: and go through from there. So thanks, Mike. 24 00:01:42,245 --> 00:01:44,565 Sheena Fraser: Thanks for joining me today. Welcome to the podcast. 25 00:01:45,585 --> 00:01:45,905 Michael Cox: Thanks. 26 00:01:46,465 --> 00:01:49,965 Sheena Fraser: Yeah. Tell me a little bit more. So I'd like, what I'd like to really start 27 00:01:49,965 --> 00:01:55,045 Sheena Fraser: with is first of all, how did you get into studying the lung microbiome? 28 00:01:55,125 --> 00:01:56,665 Sheena Fraser: Cause there's not that many of you around. 29 00:01:57,205 --> 00:02:00,885 Michael Cox: It's not, we're a weird bunch. Yeah. 30 00:02:00,905 --> 00:02:05,285 Michael Cox: So my route was a sort of, essentially a sort of field change really. 31 00:02:05,505 --> 00:02:10,165 Michael Cox: So I started out studying seawater microbial ecology. So communities of bacteria 32 00:02:10,165 --> 00:02:13,905 Michael Cox: in seawater and their impact on climate and particularly the ozone layer at 33 00:02:13,905 --> 00:02:16,725 Michael Cox: the time, and how they use trace gases. 34 00:02:17,145 --> 00:02:22,065 Michael Cox: So sort of interactions between bacteria and their environment. 35 00:02:23,225 --> 00:02:28,065 Michael Cox: And then around 2008, I took up a position at the University of California, 36 00:02:28,105 --> 00:02:33,885 Michael Cox: San Francisco, and the techniques we were using in the environmental field were 37 00:02:33,885 --> 00:02:39,325 Michael Cox: suddenly starting to gain a bit of traction in the human microbiome field or in human research. 38 00:02:40,165 --> 00:02:45,185 Michael Cox: And I got the opportunity to study people with cystic fibrosis, 39 00:02:45,265 --> 00:02:49,305 Michael Cox: or at least the samples from people with cystic fibrosis, which has always been 40 00:02:49,305 --> 00:02:54,945 Michael Cox: known as a sort of polymicrobial infection in the lungs, this chronic lung disease. 41 00:02:56,889 --> 00:02:59,909 Michael Cox: So it was really a techniques-based thing. 42 00:03:00,169 --> 00:03:04,049 Michael Cox: So rather than a bucket of seawater that I was studying and the interactions 43 00:03:04,049 --> 00:03:07,049 Michael Cox: with its environment, I was studying a bucket of sputum instead. 44 00:03:07,689 --> 00:03:11,449 Michael Cox: Nothing. Yeah, I mean, this is the field. 45 00:03:11,629 --> 00:03:17,009 Michael Cox: It's a lot of sputum is what we end up with in the lung microbiome field. 46 00:03:17,149 --> 00:03:21,429 Michael Cox: So yeah, I came following the techniques really across in that route. 47 00:03:21,429 --> 00:03:27,789 Michael Cox: And then that's expanded to other diseases and healthy lungs over the course of my research. 48 00:03:28,489 --> 00:03:32,429 Sheena Fraser: Lovely. Okay. So let's think about the lung microbiome. 49 00:03:33,069 --> 00:03:35,369 Sheena Fraser: And I'm really interested in 50 00:03:35,369 --> 00:03:40,529 Sheena Fraser: how the lung microbiome compares to the gut microbiome and how it differs. 51 00:03:40,889 --> 00:03:45,289 Sheena Fraser: So can you give us a little bit of an info on that? 52 00:03:45,749 --> 00:03:50,229 Michael Cox: So I think, I mean, it's quite different. 53 00:03:50,809 --> 00:03:57,609 Michael Cox: The key thing is that as a site, we're constantly clearing our lungs. 54 00:03:57,869 --> 00:04:01,649 Michael Cox: So we've got the mucosiliary escalator. We've got sort of rafts of mucus. 55 00:04:01,689 --> 00:04:04,229 Michael Cox: And that's designed to keep things coming out. 56 00:04:04,469 --> 00:04:08,989 Michael Cox: But we do also have a constant flow of stuff going in as well. 57 00:04:09,369 --> 00:04:13,109 Michael Cox: So we've got sort of microaspiration from saliva. 58 00:04:13,749 --> 00:04:17,569 Michael Cox: We might have bits of the oral microbiome and the nasal microbiome traveling 59 00:04:17,569 --> 00:04:20,209 Michael Cox: down into the lungs. And that's normal. 60 00:04:21,129 --> 00:04:24,569 Michael Cox: So probably there's quite a bit of micro aspiration that goes on overnight. 61 00:04:25,069 --> 00:04:31,889 Michael Cox: So it's more of a balance between these two processes of clearance and deposition, 62 00:04:32,269 --> 00:04:33,869 Michael Cox: at least in healthy people. 63 00:04:33,989 --> 00:04:39,489 Michael Cox: So the numbers of bacteria that are there are much, much lower than you see in the gut. 64 00:04:40,780 --> 00:04:45,880 Michael Cox: That doesn't necessarily mean they're not doing anything, which I think is super important because. 65 00:04:47,600 --> 00:04:52,940 Michael Cox: Quite low numbers of bacteria can have quite an impact biologically because 66 00:04:52,940 --> 00:04:57,920 Michael Cox: they do all sorts of unique things that human cells don't do. 67 00:04:58,900 --> 00:05:03,660 Michael Cox: So it's this sort of balance, this equilibrium between what goes down and what comes up. 68 00:05:03,920 --> 00:05:09,040 Michael Cox: We have only the one hole in the lungs as opposed to two. You know, 69 00:05:09,120 --> 00:05:10,480 Michael Cox: it's not the donut of the gut. 70 00:05:10,720 --> 00:05:13,540 Michael Cox: So, clearance is a slightly different process. 71 00:05:14,500 --> 00:05:19,260 Michael Cox: But yeah, numbers are different. Composition is a little bit different as well. 72 00:05:19,540 --> 00:05:23,480 Michael Cox: So, the most common organisms we find there are quite different to the most 73 00:05:23,480 --> 00:05:26,080 Michael Cox: common organisms that you'd measure in the gut microbiome. 74 00:05:26,760 --> 00:05:31,660 Michael Cox: So, the sort of top favorites are things like Streptococcus, 75 00:05:32,700 --> 00:05:38,460 Michael Cox: Prevotella and Violonella, which you can find in the gut, but not at the same abundances. 76 00:05:38,720 --> 00:05:42,180 Michael Cox: So those top three are the most abundant organisms in everyone. 77 00:05:42,560 --> 00:05:44,220 Sheena Fraser: And are those organisms, they're 78 00:05:44,220 --> 00:05:47,800 Sheena Fraser: aerobes, so organisms that like a bit of air, or are they anaerobes? 79 00:05:47,940 --> 00:05:54,420 Michael Cox: Yeah, they're weird. So what we find actually is usually you would consider 80 00:05:54,420 --> 00:06:00,000 Michael Cox: microbiologically, pre-vitella and violin anaerobes in particular, to be strict anaerobes. 81 00:06:00,260 --> 00:06:05,940 Michael Cox: They're quite hard to isolate aerobically. you'd have to usually use an anaerobic cabinet to grow them. 82 00:06:06,620 --> 00:06:11,800 Michael Cox: But we find they're the most common organisms alongside Streptococcus. 83 00:06:12,140 --> 00:06:15,740 Michael Cox: And I think that's sort of explainable by, 84 00:06:16,925 --> 00:06:21,665 Michael Cox: I mean, the lung surface is probably enriched in CO2, about 5% CO2. 85 00:06:22,025 --> 00:06:26,865 Michael Cox: If you measure right at the lung surface, you've probably got less oxygen than, 86 00:06:26,865 --> 00:06:28,745 Michael Cox: you know, in ambient air. 87 00:06:29,025 --> 00:06:33,705 Michael Cox: So maybe these organisms, we could consider them microaerophilic. 88 00:06:33,825 --> 00:06:39,645 Michael Cox: That's a sort of microbiology term for this kind of state, where they perhaps 89 00:06:39,645 --> 00:06:46,465 Michael Cox: can tolerate a little more oxygen than their sort of strict anaerobic expectations of these bugs. 90 00:06:46,465 --> 00:06:51,845 Michael Cox: But, yeah, it's sort of counterintuitive that an organism designed for use of 91 00:06:51,845 --> 00:06:55,505 Michael Cox: oxygen at the surface has these anaerobic organisms. 92 00:06:56,325 --> 00:07:04,105 Sheena Fraser: Interesting. Okay. And so they're similar in that there is a flux of organisms. 93 00:07:04,385 --> 00:07:04,625 Michael Cox: Yes. 94 00:07:04,765 --> 00:07:09,165 Sheena Fraser: But obviously in the lungs, that flux goes down and then back up. 95 00:07:09,765 --> 00:07:16,125 Sheena Fraser: And then in the gut, obviously, it goes out and then is expelled out the other end. 96 00:07:17,005 --> 00:07:22,405 Sheena Fraser: Okay. And then with the microorganisms in the lung, obviously you've got fewer of them. 97 00:07:23,365 --> 00:07:28,345 Sheena Fraser: Is it variable in different parts of the lungs? So, you know, 98 00:07:28,465 --> 00:07:31,065 Sheena Fraser: how do the end pieces, the alveoli, 99 00:07:31,405 --> 00:07:37,685 Sheena Fraser: the little air sacs right at the very end, how do they compare to the big tubes, 100 00:07:37,905 --> 00:07:39,425 Sheena Fraser: the trachea, the bronchi? 101 00:07:40,105 --> 00:07:41,385 Sheena Fraser: How do they compare? 102 00:07:42,105 --> 00:07:46,645 Michael Cox: This is really difficult because one of the challenges we have in the lungs is sampling. 103 00:07:46,945 --> 00:07:47,445 Sheena Fraser: Yeah. 104 00:07:47,645 --> 00:07:51,025 Michael Cox: So we're always sampling, usually through the mouth or nose. 105 00:07:51,585 --> 00:07:56,345 Michael Cox: So anything we find is not independent of those two sites usually. 106 00:07:57,240 --> 00:08:01,140 Michael Cox: There have been some studies of explanted lungs. 107 00:08:01,320 --> 00:08:07,000 Michael Cox: So in people who've had to have lung transplants, then some groups have looked 108 00:08:07,000 --> 00:08:10,420 Michael Cox: at the lungs that were taken out. 109 00:08:10,700 --> 00:08:14,820 Michael Cox: And that allows you to sample through the side and to be very careful that you're 110 00:08:14,820 --> 00:08:20,400 Michael Cox: not contaminating any part of the lung with any other sort of microbiological source. 111 00:08:20,720 --> 00:08:23,360 Michael Cox: And there they can see differences around the lung. 112 00:08:24,300 --> 00:08:27,840 Michael Cox: So different parts of the lung might have different bacteria, 113 00:08:28,400 --> 00:08:31,440 Michael Cox: different compositions of the microbiome present. 114 00:08:31,940 --> 00:08:36,460 Michael Cox: The caveat there is that's always end-stage lung disease because you don't get 115 00:08:36,460 --> 00:08:41,760 Michael Cox: a pair of lungs that are good lungs that you don't want to use for a transplant or some other purpose. 116 00:08:41,940 --> 00:08:46,180 Michael Cox: So it's an end-stage disease. So we don't really know, I don't think, 117 00:08:46,180 --> 00:08:51,260 Michael Cox: in healthy people about variation like that. 118 00:08:51,260 --> 00:08:56,380 Michael Cox: What we can probably say for sure, I think, is the further down the tree you 119 00:08:56,380 --> 00:09:00,420 Michael Cox: go in the lungs, the fewer organisms you would expect to see. 120 00:09:01,507 --> 00:09:06,887 Michael Cox: I think they do reach the alveoli. So, you know, we have another clearance mechanism 121 00:09:06,887 --> 00:09:13,007 Michael Cox: there, the alveolar macrophages that sort of roam around gobbling up bacteria and particles. 122 00:09:14,087 --> 00:09:18,267 Michael Cox: And they wouldn't be there if they didn't have a job to do. 123 00:09:18,587 --> 00:09:22,147 Michael Cox: And these sort of sizes of particles reach down there. 124 00:09:22,327 --> 00:09:27,987 Michael Cox: But probably there's a gradient of higher numbers at the top in the larger airways 125 00:09:27,987 --> 00:09:32,667 Michael Cox: and then fewer in the peripheral airways ways and then fewer still in the alveolar. 126 00:09:33,107 --> 00:09:36,687 Sheena Fraser: Okay and you mentioned this flux 127 00:09:36,687 --> 00:09:40,527 Sheena Fraser: from the oral microbiome and the nasal microbiome 128 00:09:40,527 --> 00:09:43,347 Sheena Fraser: so that all the little microorganisms in the mouse and 129 00:09:43,347 --> 00:09:46,607 Sheena Fraser: the nose and how they can travel down 130 00:09:46,607 --> 00:09:49,707 Sheena Fraser: into the lungs and so we're sort 131 00:09:49,707 --> 00:09:54,807 Sheena Fraser: of micro aspirating so little just inhaling little pieces of these part of these 132 00:09:54,807 --> 00:10:00,047 Sheena Fraser: microbiomes into our lungs all the time and they're they're traveling down so 133 00:10:00,047 --> 00:10:06,307 Sheena Fraser: so how does that relationship between the nose and the mouth go and what what 134 00:10:06,307 --> 00:10:08,327 Sheena Fraser: is the importance of that would you say. 135 00:10:09,259 --> 00:10:12,399 Michael Cox: This is sort of interesting, and I think inhaling as well, because the sources 136 00:10:12,399 --> 00:10:16,819 Michael Cox: of the organisms, so Streptococcus violanella prevotella, we certainly find 137 00:10:16,819 --> 00:10:18,119 Michael Cox: in the oral cavity as well. 138 00:10:20,179 --> 00:10:26,759 Michael Cox: Those probably not the major organisms in the nasopharynx, in the nasal cavity. 139 00:10:27,119 --> 00:10:30,539 Michael Cox: So there are certain things that are unique to these environments as well. 140 00:10:30,859 --> 00:10:37,399 Michael Cox: So the nose, you often see things like Delosigranulum and Carinobacterium. 141 00:10:37,559 --> 00:10:38,779 Michael Cox: I love some of these names. 142 00:10:39,259 --> 00:10:46,859 Michael Cox: Um, but, uh, you know, we don't see those routinely in samples from the lung 143 00:10:46,859 --> 00:10:48,219 Michael Cox: or lower down in the lung. 144 00:10:48,559 --> 00:10:52,519 Michael Cox: Um, similarly, there are a lot of organisms that are associated with dentition 145 00:10:52,519 --> 00:10:56,699 Michael Cox: with teeth, with sort of cruvicular fluids, that, that fluid that builds up 146 00:10:56,699 --> 00:11:01,639 Michael Cox: between your teeth and your gums that are quite unique to that site that we 147 00:11:01,639 --> 00:11:02,719 Michael Cox: don't see in the lungs as well. 148 00:11:02,819 --> 00:11:06,999 Michael Cox: So there's some process of selection going on here. There are things that are 149 00:11:06,999 --> 00:11:09,899 Michael Cox: either easier to get into the lungs... 150 00:11:10,840 --> 00:11:14,460 Michael Cox: Or tend to stick around a bit there. 151 00:11:14,980 --> 00:11:19,160 Michael Cox: And that's a very hard thing to measure, partly because of how you sample, 152 00:11:19,260 --> 00:11:21,040 Michael Cox: and sampling over time is what you need to do. 153 00:11:21,240 --> 00:11:25,220 Michael Cox: But probably there is something like that, because across different people, 154 00:11:25,820 --> 00:11:29,420 Michael Cox: we always see those three dominant organisms in health. 155 00:11:29,700 --> 00:11:33,940 Michael Cox: There's something about that environment that allows them to be there. 156 00:11:34,080 --> 00:11:35,300 Michael Cox: We don't know what that is. 157 00:11:35,480 --> 00:11:37,040 Sheena Fraser: Okay, so they're the travelers. 158 00:11:37,680 --> 00:11:40,820 Michael Cox: Yes, yeah, I think so. resident 159 00:11:40,820 --> 00:11:43,720 Michael Cox: is would be a controversial term because you've got 160 00:11:43,720 --> 00:11:47,840 Michael Cox: this process of them moving out we don't even know whether there's growth in 161 00:11:47,840 --> 00:11:52,900 Michael Cox: there so in the gut for example it's repopulated because you know that there's 162 00:11:52,900 --> 00:11:57,120 Michael Cox: bacteria definitely growing in in your gut we don't know that whether the ones 163 00:11:57,120 --> 00:12:02,960 Michael Cox: in your lungs are actively growing in situ which would add which would shift that balance as well so. 164 00:12:02,960 --> 00:12:05,980 Sheena Fraser: Then maybe we should talk about what they're actually doing there um. 165 00:12:07,640 --> 00:12:12,600 Michael Cox: Hey that's my that's my job that's that's the million dollar question yeah so. 166 00:12:12,600 --> 00:12:16,560 Sheena Fraser: What are these bugs doing in our lungs what what is the purpose. 167 00:12:16,560 --> 00:12:22,600 Michael Cox: I mean i just think they're sort of i always like to think of humans as sort 168 00:12:22,600 --> 00:12:27,500 Michael Cox: of meat puppets and and i'm i'm i'm all about the bacteria when it comes to 169 00:12:27,500 --> 00:12:35,060 Michael Cox: this but they're just hanging out having a good time i streps probably the streptococcus is, you know, 170 00:12:35,340 --> 00:12:42,300 Michael Cox: existing on the mucin that we produce, and that's produced constantly, 171 00:12:42,880 --> 00:12:47,020 Michael Cox: and as well as being removed, probably being degraded by the streptococci as well. 172 00:12:47,220 --> 00:12:51,020 Michael Cox: I think probably Prevatella and Violonella have roles there as well. 173 00:12:51,200 --> 00:12:53,860 Michael Cox: So they're sort of happy grazers. 174 00:12:55,460 --> 00:13:03,280 Michael Cox: Positive impacts are sort of hard to show. So, there's a little bit of evidence 175 00:13:03,280 --> 00:13:07,120 Michael Cox: that certain organisms might interact with inflammation. 176 00:13:08,474 --> 00:13:16,034 Michael Cox: So there's one called Rothia mucilaginosa that some people have shown in vitro, 177 00:13:16,034 --> 00:13:18,134 Michael Cox: at least, in lab experiments. 178 00:13:18,514 --> 00:13:21,434 Michael Cox: Some strains of it can impact inflammation. 179 00:13:22,614 --> 00:13:28,194 Michael Cox: But this kind of research in the lungs, you know, it's more common to talk about 180 00:13:28,194 --> 00:13:32,474 Michael Cox: those kind of interactions in the gut microbiome because it's a tough site to 181 00:13:32,474 --> 00:13:34,074 Michael Cox: sample and to understand. 182 00:13:34,794 --> 00:13:40,794 Michael Cox: That research lags in the lungs. So there might be interactions there that sort 183 00:13:40,794 --> 00:13:42,654 Michael Cox: of dampen down inflammatory responses, 184 00:13:42,654 --> 00:13:46,894 Michael Cox: but there's certainly plenty that increase inflammatory responses because we 185 00:13:46,894 --> 00:13:50,294 Michael Cox: know about the sort of lung infection pathogens and stuff. 186 00:13:50,914 --> 00:13:55,954 Sheena Fraser: Yeah. And so we know from the oral microbiome as well that they can play a role 187 00:13:55,954 --> 00:14:02,834 Sheena Fraser: in your initial fighting off of infections. 188 00:14:03,494 --> 00:14:09,954 Sheena Fraser: So, you know, some of the more mucus-dwelling bacteria, they play a role with 189 00:14:09,954 --> 00:14:15,294 Sheena Fraser: IgA, like lactobacillus plays a role with IgA. Are there any lactobacillus in the lungs? 190 00:14:15,514 --> 00:14:19,954 Michael Cox: Yeah, you can detect them. We don't know. Again, we don't know what they're doing. 191 00:14:20,294 --> 00:14:26,514 Michael Cox: Um, the abundance isn't very high because, so it's a low abundance environment altogether. 192 00:14:26,834 --> 00:14:30,994 Michael Cox: And then they're not the most common ones, but you can detect them. 193 00:14:31,334 --> 00:14:35,274 Michael Cox: Um, but similarly in the gut, they're not necessarily in the most abundant ones. 194 00:14:35,414 --> 00:14:40,734 Michael Cox: I think probably of these kind of sort of, we call them commensals where they're 195 00:14:40,734 --> 00:14:45,314 Michael Cox: not having, where they're there, but we don't know what they're doing and they 196 00:14:45,314 --> 00:14:47,454 Michael Cox: might not be having a positive or negative effect. 197 00:14:47,454 --> 00:14:50,574 Michael Cox: They might just be sort of hanging out the, 198 00:14:52,196 --> 00:14:57,736 Michael Cox: I wonder whether the streps are going to be more, those abundant ones are going 199 00:14:57,736 --> 00:15:01,856 Michael Cox: to be more important in terms of interactions with us. 200 00:15:02,816 --> 00:15:06,676 Michael Cox: Because they do produce, streptococcus produces lactic acid, 201 00:15:06,896 --> 00:15:09,736 Michael Cox: lactate, as a normal part of its metabolism. 202 00:15:10,396 --> 00:15:16,756 Michael Cox: It is technically in the larger group of lactic acid um producers of which lactobacillus 203 00:15:16,756 --> 00:15:24,016 Michael Cox: is a relative so um yeah you can detect it we don't know again what it's doing 204 00:15:24,016 --> 00:15:28,676 Michael Cox: that's going to be a common theme i think when i'm talking about the microbiome i. 205 00:15:28,676 --> 00:15:34,796 Sheena Fraser: Know absolutely absolutely i yeah i did come across a paper um that looked at 206 00:15:34,796 --> 00:15:43,936 Sheena Fraser: the impact of some probiotics on lungs and um and lactobacillus helvetius or. 207 00:15:43,936 --> 00:15:45,256 Michael Cox: Health yeah. 208 00:15:45,256 --> 00:15:51,296 Sheena Fraser: Helvetius which is not one i'd heard of before um evidently has a positive effect 209 00:15:51,296 --> 00:15:56,916 Sheena Fraser: on the lung microbiome by increasing iga in the mucosa which is sort of an early 210 00:15:56,916 --> 00:15:58,836 Sheena Fraser: defense against respiratory pathogens, 211 00:15:59,456 --> 00:16:05,636 Sheena Fraser: um which is interesting um but you know i don't know whether the you um i don't 212 00:16:05,636 --> 00:16:07,776 Sheena Fraser: know where you get helvetica's from. 213 00:16:07,776 --> 00:16:11,156 Michael Cox: No and it's really difficult because lots 214 00:16:11,156 --> 00:16:17,596 Michael Cox: of the ways we measure these things are not very good so so a lot of the sequencing 215 00:16:17,596 --> 00:16:23,196 Michael Cox: techniques that we have to use so you can you can isolate bacteria but we don't 216 00:16:23,196 --> 00:16:28,156 Michael Cox: isolate all of them because you have to use a huge range of conditions to actually isolate them. 217 00:16:28,396 --> 00:16:32,856 Michael Cox: So we're always sort of sub-sampling when we try and grow something because 218 00:16:32,856 --> 00:16:34,396 Michael Cox: we will be missing a bunch of stuff. 219 00:16:34,676 --> 00:16:36,956 Michael Cox: So we use a lot of DNA sequencing techniques. 220 00:16:37,908 --> 00:16:42,548 Michael Cox: The issue with those is identifying the organism. 221 00:16:43,128 --> 00:16:48,588 Michael Cox: So firstly, knowing which one it is, because maybe we'll only get a genus name, 222 00:16:48,808 --> 00:16:54,568 Michael Cox: but we know that the impact to probiotics, we know that pathogenicity is definitely 223 00:16:54,568 --> 00:16:57,008 Michael Cox: a strain or substrain level property. 224 00:16:57,008 --> 00:17:00,968 Michael Cox: So we're not accessing that information. We're just sort of, 225 00:17:01,068 --> 00:17:02,028 Michael Cox: we're finding the village. 226 00:17:02,368 --> 00:17:04,948 Michael Cox: We're not finding the address. 227 00:17:05,808 --> 00:17:11,368 Michael Cox: So there's that issue. The other one is that the sequencing techniques have 228 00:17:11,368 --> 00:17:17,108 Michael Cox: this property that they are relative abundance methods. They're not quantitative. 229 00:17:17,968 --> 00:17:25,828 Michael Cox: So on the whole, what you do is you sequence and it's a proportion that you see. 230 00:17:26,488 --> 00:17:34,428 Michael Cox: If something increases in abundance, we don't know whether it's increasing itself 231 00:17:34,428 --> 00:17:37,228 Michael Cox: and everything else is staying at the same level. 232 00:17:37,228 --> 00:17:43,508 Michael Cox: Or it's increasing and we're pushing everything else out of the ability to sample it. 233 00:17:44,788 --> 00:17:51,028 Michael Cox: So that makes everything really difficult. So we can usually see if something 234 00:17:51,028 --> 00:17:52,328 Michael Cox: has increased in abundance. 235 00:17:52,748 --> 00:17:55,468 Michael Cox: We can't see decreases with this method. 236 00:17:56,468 --> 00:18:03,548 Michael Cox: So where that becomes particularly important for understanding interactions 237 00:18:03,548 --> 00:18:07,668 Michael Cox: between organisms is that we can't see negative interactions. 238 00:18:07,828 --> 00:18:09,648 Michael Cox: People will assume them, 239 00:18:10,568 --> 00:18:14,248 Michael Cox: Because we think of it in competition. If something's increased and something 240 00:18:14,248 --> 00:18:17,368 Michael Cox: else has gone, we think, oh, they're in competition with each other. 241 00:18:17,528 --> 00:18:19,768 Michael Cox: But actually, the technique can't tell us that. 242 00:18:19,988 --> 00:18:23,248 Michael Cox: We need a real quantitative technique. 243 00:18:23,568 --> 00:18:28,528 Michael Cox: So if you're reading papers about this, what you'd like to see there is somebody 244 00:18:28,528 --> 00:18:36,228 Michael Cox: do a specific qPCR or a specific sort of isolation of those two organisms to 245 00:18:36,228 --> 00:18:39,428 Michael Cox: confirm whether they're genuinely in competition with each other. 246 00:18:39,428 --> 00:18:45,808 Michael Cox: Or in fact it's just that that method hasn't been sensitive enough to detect 247 00:18:45,808 --> 00:18:48,848 Michael Cox: the change or lack of change in one of them. 248 00:18:50,048 --> 00:18:56,048 Michael Cox: So yeah, that sort of competition thing which has got to be essential to understanding 249 00:18:56,048 --> 00:18:59,308 Michael Cox: infection and protection against 250 00:18:59,308 --> 00:19:04,568 Michael Cox: infection is something we are not good at generally with this technique. 251 00:19:05,328 --> 00:19:06,968 Michael Cox: So we have to be quite careful. 252 00:19:06,968 --> 00:19:14,028 Sheena Fraser: And I guess from that technique, we're sort of assuming function. Yeah, always. 253 00:19:14,408 --> 00:19:19,108 Sheena Fraser: Whereas, you know, now we should be looking at function a little bit more, 254 00:19:19,328 --> 00:19:23,968 Sheena Fraser: you know, rather than just considering who's there and how many of them are there. 255 00:19:24,528 --> 00:19:28,308 Sheena Fraser: You know, what are they actually doing and what are they producing? 256 00:19:30,268 --> 00:19:35,288 Sheena Fraser: So are there any studies on function of these organisms in the lungs? 257 00:19:35,288 --> 00:19:41,308 Michael Cox: So in the lungs, far fewer, because it's hard to look at function in situ. 258 00:19:43,388 --> 00:19:47,888 Michael Cox: It's really interesting to me because this parallels all the questions we had 259 00:19:47,888 --> 00:19:50,128 Michael Cox: in environmental microbiology 20 years ago. 260 00:19:50,128 --> 00:19:56,568 Michael Cox: So we started by trying to like profiling what was there and then associating 261 00:19:56,568 --> 00:19:58,408 Michael Cox: that with measures in the environment. 262 00:19:58,668 --> 00:20:04,548 Michael Cox: So in the human sort of study, we're measuring what's there and associating 263 00:20:04,548 --> 00:20:05,588 Michael Cox: that often with disease. 264 00:20:07,583 --> 00:20:10,943 Michael Cox: Disease is really actually a far down the line process. 265 00:20:11,623 --> 00:20:14,763 Michael Cox: It's not what's actually happening. 266 00:20:15,043 --> 00:20:19,003 Michael Cox: It's not what the organism is experiencing. It's not what the cells are experiencing. 267 00:20:19,003 --> 00:20:20,863 Michael Cox: It's the ultimate endpoint. 268 00:20:21,163 --> 00:20:23,863 Michael Cox: A lot of life has happened alongside that. 269 00:20:24,643 --> 00:20:30,683 Michael Cox: So those associations, I think, are going to be, you know, at the moment they're quite distant. 270 00:20:31,003 --> 00:20:34,383 Michael Cox: A lot of people measure lung function in microbiome studies. 271 00:20:34,383 --> 00:20:37,183 Michael Cox: Trying to find an organism or a group 272 00:20:37,183 --> 00:20:39,983 Michael Cox: of organisms that relates to lung function at 273 00:20:39,983 --> 00:20:46,123 Michael Cox: all usually it's negative however you know that doesn't mean it's not important 274 00:20:46,123 --> 00:20:51,223 Michael Cox: um it means we're potentially measuring something so far distant from what it 275 00:20:51,223 --> 00:20:57,123 Michael Cox: is the processes that are actually going on um in vitro so you can look at function 276 00:20:57,123 --> 00:20:59,703 Michael Cox: of organisms we're quite good at sort of measuring. 277 00:21:01,583 --> 00:21:04,443 Michael Cox: You can use models to look at how virulent they are. 278 00:21:04,803 --> 00:21:10,303 Michael Cox: You can use models to look at whether there's interactions with the immune system in some way. 279 00:21:11,183 --> 00:21:16,363 Michael Cox: Those models are always a compromise. They're always something slightly different 280 00:21:16,363 --> 00:21:17,883 Michael Cox: to what's going on in the human. 281 00:21:18,223 --> 00:21:23,723 Michael Cox: So one of the things I think lots of people in this field are trying to do at 282 00:21:23,723 --> 00:21:27,883 Michael Cox: the moment is to try to try and find good models to answer particular questions. 283 00:21:28,243 --> 00:21:29,963 Michael Cox: And that's everything from, 284 00:21:31,030 --> 00:21:34,890 Michael Cox: you know, just changing the media that you're growing the bacteria in to make 285 00:21:34,890 --> 00:21:36,430 Michael Cox: it look a bit more like an airway. 286 00:21:36,690 --> 00:21:39,790 Michael Cox: So literally adding some pig lung mucin 287 00:21:39,790 --> 00:21:42,830 Michael Cox: to that or pig stomach mucin to 288 00:21:42,830 --> 00:21:46,050 Michael Cox: your culture to see how it interacts with mucin to 289 00:21:46,050 --> 00:21:49,570 Michael Cox: models that are sort of organoids 290 00:21:49,570 --> 00:21:53,410 Michael Cox: where you build up a 3D cell culture 291 00:21:53,410 --> 00:21:57,030 Michael Cox: where you start to see ciliated cells 292 00:21:57,030 --> 00:22:00,050 Michael Cox: that you would expect to see in the lungs as well that's so 293 00:22:00,050 --> 00:22:03,410 Michael Cox: intensive that you know adding bacteria 294 00:22:03,410 --> 00:22:06,190 Michael Cox: to that is a is a risky maneuver because you get it 295 00:22:06,190 --> 00:22:10,390 Michael Cox: wrong and you just you've ruined your cell culture as opposed to achieved something 296 00:22:10,390 --> 00:22:14,150 Michael Cox: in terms of understanding interaction but yeah it's it's what everybody is trying 297 00:22:14,150 --> 00:22:19,470 Michael Cox: to do at the moment um i'd love to do more stuff that's closer to the reality 298 00:22:19,470 --> 00:22:24,210 Michael Cox: of the lungs and and disease um and so would everybody else yeah. 299 00:22:24,210 --> 00:22:28,590 Sheena Fraser: So i'm getting the impression here that it's not an easy subject that you're 300 00:22:28,590 --> 00:22:31,710 Sheena Fraser: studying here this is not this is not an easy field. 301 00:22:31,710 --> 00:22:38,870 Michael Cox: I don't I mean I it's sort of why I like microbiome because it's it's um as a as a topic it's, 302 00:22:39,570 --> 00:22:43,570 Michael Cox: because it's important. We know it's important. We know that there are direct 303 00:22:43,570 --> 00:22:45,210 Michael Cox: interactions with people. 304 00:22:45,390 --> 00:22:50,770 Michael Cox: We know it's probably going to relate to both health and disease, but it's so confounded. 305 00:22:51,330 --> 00:22:56,390 Michael Cox: There's so many things where maybe we're measuring the right thing, maybe we're not. 306 00:22:56,970 --> 00:23:02,230 Michael Cox: Maybe it's related to this aspect of disease, maybe it isn't. 307 00:23:02,350 --> 00:23:03,510 Michael Cox: It's full of red herrings. 308 00:23:03,670 --> 00:23:07,630 Michael Cox: That actually makes it quite interesting to try and pick all that apart. 309 00:23:07,630 --> 00:23:14,430 Michael Cox: Um so so that's why i like it but yeah it's it's a bit messy okay. 310 00:23:14,430 --> 00:23:18,050 Sheena Fraser: Well let's talk about things that we can kind of. 311 00:23:18,050 --> 00:23:19,070 Michael Cox: Okay already. 312 00:23:19,070 --> 00:23:24,550 Sheena Fraser: Say about it so so let's talk about the influencers on the the lung microbiome 313 00:23:24,550 --> 00:23:29,350 Sheena Fraser: um i've got a list of things that i think are influencers. 314 00:23:29,350 --> 00:23:32,090 Michael Cox: On microbiome let's. 315 00:23:32,090 --> 00:23:35,370 Sheena Fraser: Go through them and then you can tell me whether they are or they aren't. 316 00:23:35,370 --> 00:23:39,870 Michael Cox: It'll probably be maybe a lot of maybes but go on okay. 317 00:23:39,870 --> 00:23:42,090 Sheena Fraser: All right so first of all pollution. 318 00:23:42,090 --> 00:23:45,530 Michael Cox: I think probably yeah so so we 319 00:23:45,530 --> 00:23:49,130 Michael Cox: know that there's um so one 320 00:23:49,130 --> 00:23:53,130 Michael Cox: of the proxies we have for an influence on my a 321 00:23:53,130 --> 00:23:58,930 Michael Cox: microbial community is whether we see any impact on infection so if there's 322 00:23:58,930 --> 00:24:03,170 Michael Cox: more pollution about this probably you've got higher chances of getting infection 323 00:24:03,170 --> 00:24:08,330 Michael Cox: we can probably anticipate therefore that there's an impact directly on the 324 00:24:08,330 --> 00:24:09,530 Michael Cox: microorganisms in the lungs. 325 00:24:09,810 --> 00:24:17,990 Michael Cox: People have shown that pollution and smoking can change how, 326 00:24:18,810 --> 00:24:22,070 Michael Cox: bacteria interact with lung cells so 327 00:24:22,070 --> 00:24:24,890 Michael Cox: it might make them a bit stickier might make them a bit 328 00:24:24,890 --> 00:24:29,250 Michael Cox: more pathogenic that changes their expression so yes 329 00:24:29,250 --> 00:24:32,590 Michael Cox: i would say pollution um does have 330 00:24:32,590 --> 00:24:35,770 Michael Cox: an impact there on the microbiome and quantifying it 331 00:24:35,770 --> 00:24:41,510 Michael Cox: across all these organisms um because there's quite a few of them at any one 332 00:24:41,510 --> 00:24:47,330 Michael Cox: time in a population of people you're going to see a lot of difference there 333 00:24:47,330 --> 00:24:50,690 Michael Cox: in responses so there's a lot of other things that interact with that but yeah 334 00:24:50,690 --> 00:24:53,010 Michael Cox: for sure pollution i think is a good one and. 335 00:24:53,010 --> 00:24:57,070 Sheena Fraser: I guess there's lots of stuff in pollution that behaves differently. 336 00:24:57,070 --> 00:24:59,970 Michael Cox: Not one thing yeah one thing exactly because. 337 00:24:59,970 --> 00:25:04,710 Sheena Fraser: There's there's gases and there's metal heavy metals and there's particles. 338 00:25:04,710 --> 00:25:07,090 Michael Cox: And um. 339 00:25:07,090 --> 00:25:10,750 Sheena Fraser: You know there's lots of different things there that will have slightly different 340 00:25:10,750 --> 00:25:14,850 Sheena Fraser: impacts as well on the lungs and the, and the microorganisms. 341 00:25:15,010 --> 00:25:22,070 Sheena Fraser: Um, but, but my, I would have thought that most of them are pro-inflammatory, um, 342 00:25:22,470 --> 00:25:26,490 Sheena Fraser: and, and creating some degree of inflammation in the lungs, 343 00:25:26,790 --> 00:25:30,050 Sheena Fraser: either through a direct mechanism on the 344 00:25:30,050 --> 00:25:33,610 Sheena Fraser: tissues or an indirect mechanism via the 345 00:25:33,610 --> 00:25:40,050 Sheena Fraser: microbes or the um or other other things that it's shifting in the community 346 00:25:40,050 --> 00:25:46,070 Sheena Fraser: and in the environment yeah um you know disabling the cilia um the little hairs 347 00:25:46,070 --> 00:25:51,930 Sheena Fraser: um you know doing things like that that stops the the mucus from traveling up and down yeah. 348 00:25:51,930 --> 00:25:55,210 Michael Cox: So we know that that has an impact using sort of, 349 00:25:56,127 --> 00:26:00,547 Michael Cox: again, a sort of proxy in disease where cystic fibrosis, for example, 350 00:26:01,307 --> 00:26:07,527 Michael Cox: mucus is thicker, so the ciliary beat is less effective, and that leads to a 351 00:26:07,527 --> 00:26:10,047 Michael Cox: buildup of mucus, which gets infected. 352 00:26:10,407 --> 00:26:16,067 Michael Cox: And there's a sort of related but quite different mechanism in another disease 353 00:26:16,067 --> 00:26:20,247 Michael Cox: called primary ciliary dystynesia, where there the mucus is normal, 354 00:26:20,467 --> 00:26:24,927 Michael Cox: but the cilia don't beat properly, so they're not shifting. 355 00:26:25,567 --> 00:26:29,807 Michael Cox: And there we see similar chronic infections, but actually slightly different 356 00:26:29,807 --> 00:26:31,127 Michael Cox: combination of organisms. 357 00:26:31,787 --> 00:26:36,727 Michael Cox: So I think that's kind of interesting how, you know, ecologically the environment 358 00:26:36,727 --> 00:26:37,727 Michael Cox: is a little bit different. 359 00:26:37,987 --> 00:26:43,987 Michael Cox: So those two things that aren't quite the same and therefore we see slightly different organisms. 360 00:26:44,207 --> 00:26:48,027 Michael Cox: We're getting back to pollution as well. I think the other thing to remember 361 00:26:48,027 --> 00:26:52,627 Michael Cox: is that bacteria are biological entities as well. 362 00:26:52,627 --> 00:26:56,907 Michael Cox: So if there's something that's a bit toxic that's about, often those things 363 00:26:56,907 --> 00:27:02,907 Michael Cox: are sort of quite generally toxic or dangerous to living cells. 364 00:27:02,927 --> 00:27:05,047 Michael Cox: They will affect the organisms too. 365 00:27:06,587 --> 00:27:10,647 Michael Cox: So we did a population study a number of years ago. 366 00:27:11,007 --> 00:27:18,647 Michael Cox: So this is when I was based at Imperial College in collaboration with a big 367 00:27:18,647 --> 00:27:22,047 Michael Cox: population study in the town of Busselton in Western Australia. 368 00:27:23,607 --> 00:27:28,647 Michael Cox: And there we looked at throat swabs, the back of the throat, 369 00:27:28,947 --> 00:27:34,807 Michael Cox: which is sort of a good overlap with what's in the lungs in healthy people. 370 00:27:35,307 --> 00:27:41,647 Michael Cox: So rather than doing hundreds of bronchoscopies across this town of Busselton, 371 00:27:41,887 --> 00:27:45,467 Michael Cox: we took throat swabs from an ongoing health study. 372 00:27:45,907 --> 00:27:49,507 Michael Cox: And there we saw a really clear relationship with smoking. 373 00:27:49,507 --> 00:27:55,167 Michael Cox: So people who'd smoked longer 374 00:27:55,167 --> 00:27:58,407 Michael Cox: or a large amount or had 375 00:27:58,407 --> 00:28:03,907 Michael Cox: ever smoked and then quit had different combinations of organisms in their lungs 376 00:28:03,907 --> 00:28:08,967 Michael Cox: but the impact of smoking seemed to be that total numbers of bacteria were down 377 00:28:08,967 --> 00:28:15,207 Michael Cox: so you know there's there's reactive oxygen species in caused by cigarette smoking, 378 00:28:15,467 --> 00:28:18,167 Michael Cox: there's toxic compounds in cigarette smoke. 379 00:28:18,327 --> 00:28:22,187 Michael Cox: So they've had an impact on the bacteria. As well as causing inflammation, 380 00:28:22,207 --> 00:28:24,547 Michael Cox: you've got fewer bacteria present in the lungs. 381 00:28:24,907 --> 00:28:28,787 Michael Cox: But interestingly, some of them survived a little better. So everything was 382 00:28:28,787 --> 00:28:32,007 Michael Cox: down, but the streptococci were down less. 383 00:28:32,407 --> 00:28:38,427 Michael Cox: So in terms of the composition, you see the skew to everything becoming streptococcus. 384 00:28:39,047 --> 00:28:45,387 Michael Cox: Now, if streptococcus has a particular function, and now it finds itself freed 385 00:28:45,387 --> 00:28:49,907 Michael Cox: from all these other organisms and in a more inflamed environment. 386 00:28:50,907 --> 00:28:52,987 Michael Cox: What happens to its function there? 387 00:28:53,167 --> 00:28:57,587 Michael Cox: Is it still functioning as it was when it was a commensal? Is it now doing something 388 00:28:57,587 --> 00:29:05,427 Michael Cox: else which may be cycling and helping to increase the inflammation that you have there anyway? 389 00:29:07,007 --> 00:29:10,667 Michael Cox: Interestingly we think we saw this, 390 00:29:11,827 --> 00:29:17,307 Michael Cox: was you know we didn't quite have the numbers to be certain about this but what 391 00:29:17,307 --> 00:29:22,247 Michael Cox: we thought we saw as well was that as people stopped smoking, 392 00:29:23,463 --> 00:29:28,483 Michael Cox: the lung microbiome returned to normal. So it started looking like a healthy one. 393 00:29:28,703 --> 00:29:37,763 Michael Cox: And the longer ago you quit, the closer to what we usually see in healthy non-smokers was the case. 394 00:29:37,903 --> 00:29:42,183 Michael Cox: So it's the same as, you know, stopping smoking has an impact, 395 00:29:42,403 --> 00:29:45,963 Michael Cox: a positive impact on your lung microbiome too. 396 00:29:46,303 --> 00:29:50,263 Sheena Fraser: Did you see a point where it normalized or was that different for different people? 397 00:29:51,123 --> 00:29:53,943 Michael Cox: So this is this is where it gets because we didn't quite 398 00:29:53,943 --> 00:29:57,723 Michael Cox: have the the sort of range in numbers of age 399 00:29:57,723 --> 00:30:03,643 Michael Cox: or time since people had stopped smoking to be sure about that um so length 400 00:30:03,643 --> 00:30:09,183 Michael Cox: of time really hard to say and probably quite inaccurate but five to ten years 401 00:30:09,183 --> 00:30:14,943 Michael Cox: you know that kind of range of time but i think would be reasonable so. 402 00:30:14,943 --> 00:30:21,103 Sheena Fraser: We know now that pollution and smoking are definite impactors. Yes. What about vaping? 403 00:30:22,052 --> 00:30:29,032 Michael Cox: Vaping, what is this space? So we're just starting with collaborators, 404 00:30:29,032 --> 00:30:30,472 Michael Cox: a project around vaping. 405 00:30:31,272 --> 00:30:37,212 Michael Cox: So Dr. Aaron Scott at the University of Birmingham is an immunologist and he's 406 00:30:37,212 --> 00:30:44,412 Michael Cox: looking at inflammation in the context of using either vaping or nicotine patches 407 00:30:44,412 --> 00:30:46,172 Michael Cox: to help you stop smoking. 408 00:30:48,612 --> 00:30:52,992 Michael Cox: So our contribution to that study will be looking at the microbiome in that 409 00:30:52,992 --> 00:30:58,392 Michael Cox: context as well I'd imagine it probably has an impact I'd imagine it was probably 410 00:30:58,392 --> 00:31:04,312 Michael Cox: a little bit different to cigarette smoke because it's a different range of 411 00:31:04,312 --> 00:31:06,412 Michael Cox: compounds that you're being exposed to, 412 00:31:07,372 --> 00:31:12,792 Michael Cox: I think the thing to remember with vaping as well is how variable it is because 413 00:31:12,792 --> 00:31:20,532 Michael Cox: it's not regulated sort of market in the same way as cigarettes and smoking. 414 00:31:20,932 --> 00:31:26,612 Michael Cox: And there's a lot of flavour compounds that go in there, a big variety of them. 415 00:31:26,892 --> 00:31:32,952 Michael Cox: So what happens to them when they're heated, how those interact with our own 416 00:31:32,952 --> 00:31:36,352 Michael Cox: cells, all the bacterial cells, the microbiome that's there, 417 00:31:36,552 --> 00:31:38,812 Michael Cox: is going to be unpredictable. 418 00:31:39,352 --> 00:31:42,692 Sheena Fraser: Yeah, and I think I've read one paper that has looked, 419 00:31:43,643 --> 00:31:49,843 Sheena Fraser: at the impact of vaping already and, and found that those flavors and the, 420 00:31:50,083 --> 00:31:56,163 Sheena Fraser: um, yeah, the, the, the flavors when they're, um, initiated into lungs do create 421 00:31:56,163 --> 00:31:58,303 Sheena Fraser: some inflammation as you would imagine. 422 00:31:58,523 --> 00:31:58,823 Michael Cox: Yeah. 423 00:31:59,063 --> 00:32:04,283 Sheena Fraser: Um, but the other thing is the heating element in the, in the vape, um, 424 00:32:04,823 --> 00:32:08,783 Sheena Fraser: because the heating element actually gives off a whole load of, um, 425 00:32:09,143 --> 00:32:14,363 Sheena Fraser: metals and you inhale a load of metals and, And they've actually found quite 426 00:32:14,363 --> 00:32:22,763 Sheena Fraser: a lot of different metals in the lungs, chromium and tin and aluminium and all sorts of things. 427 00:32:22,843 --> 00:32:25,803 Sheena Fraser: And a lot of these metals are actually quite inflammatory as well. 428 00:32:26,043 --> 00:32:28,403 Sheena Fraser: Aluminium is very inflammatory in the lungs. 429 00:32:28,723 --> 00:32:35,723 Sheena Fraser: So that's an interesting one as well. And just the heat, I think, from vaping. 430 00:32:36,343 --> 00:32:45,523 Sheena Fraser: Because heat in its own right can create inflammation. but also the DNA damage in cells, can't it? 431 00:32:45,923 --> 00:32:50,743 Michael Cox: Yeah, it's such a difficult topic because one of the things I think concerns 432 00:32:50,743 --> 00:32:56,523 Michael Cox: me as well is the age of people vaping is also much, much younger. 433 00:32:56,823 --> 00:33:01,703 Michael Cox: And what we're actually talking about, there are sort of developing lungs, 434 00:33:01,883 --> 00:33:07,823 Michael Cox: lungs that are still developing and causing damage to them early on, 435 00:33:11,243 --> 00:33:15,443 Michael Cox: is likely to store up issues for later. 436 00:33:16,923 --> 00:33:22,243 Michael Cox: As a smoking cessation tool, it's a little bit more nuanced because there you're 437 00:33:22,243 --> 00:33:23,863 Michael Cox: talking about, is it better than... 438 00:33:25,118 --> 00:33:29,918 Michael Cox: Cigarette smoke and it's a relative thing. So if it's helping people to stop 439 00:33:29,918 --> 00:33:34,618 Michael Cox: smoking and while it might still be damaging, it's better than smoking, 440 00:33:35,058 --> 00:33:38,718 Michael Cox: it's trying to measure a sort of relative risk there. 441 00:33:39,938 --> 00:33:45,478 Michael Cox: But I think it's probably safe to say if you've managed to stop smoking by vaping, 442 00:33:45,658 --> 00:33:49,778 Michael Cox: it would probably be good to be trying to stop vaping after that as well because 443 00:33:49,778 --> 00:33:55,618 Michael Cox: nicotine in and of itself is is not a great thing to be to be getting into your body. 444 00:33:55,618 --> 00:33:58,598 Sheena Fraser: Yeah nicotine on an adolescent brain as 445 00:33:58,598 --> 00:34:01,658 Sheena Fraser: well is very harmful it can cause behavioral problems 446 00:34:01,658 --> 00:34:05,518 Sheena Fraser: and mood problems um interestingly um 447 00:34:05,518 --> 00:34:12,078 Sheena Fraser: i mean i i looked up 10 of our adolescent are vaping now and i and i wonder 448 00:34:12,078 --> 00:34:17,398 Sheena Fraser: actually if that's even higher in my my local kids school as well because uh 449 00:34:17,398 --> 00:34:21,858 Sheena Fraser: talking to my own children about how many kids in their year are vaping. 450 00:34:22,378 --> 00:34:27,298 Sheena Fraser: And actually, you're more likely to smoke if you start off vaping. 451 00:34:27,518 --> 00:34:28,078 Michael Cox: Yeah. 452 00:34:28,378 --> 00:34:31,818 Sheena Fraser: Yeah. As much as it's been used as a way of stopping smoking, 453 00:34:32,018 --> 00:34:36,238 Sheena Fraser: it actually may initiate you towards smoking as well, which is not wonderful. 454 00:34:37,258 --> 00:34:43,458 Sheena Fraser: Yeah, I have my concerns about vaping. And, you know, I've seen young patients 455 00:34:43,458 --> 00:34:50,678 Sheena Fraser: coming along with serious vaping habits, equivalent to, you know, 20 cigarettes a day. 456 00:34:51,038 --> 00:34:54,658 Sheena Fraser: And whilst I agree, they're probably safer than cigarettes. 457 00:34:55,753 --> 00:35:00,013 Sheena Fraser: There's still a risk there. And I think that really needs to be ironed out. 458 00:35:00,113 --> 00:35:05,093 Sheena Fraser: And I think our children need to be kept away from vapes as much as possible 459 00:35:05,093 --> 00:35:08,353 Sheena Fraser: to preserve their developing lungs. 460 00:35:08,793 --> 00:35:12,313 Michael Cox: Yeah, there's a difference there, isn't there, between somebody who's maybe 461 00:35:12,313 --> 00:35:20,013 Michael Cox: in their 50s and has smoked their entire life and needs to get off cigarettes for their lung health. 462 00:35:20,013 --> 00:35:28,173 Michael Cox: That's different to a sort of 12, 13, 14 year olds with growing, 463 00:35:28,453 --> 00:35:33,333 Michael Cox: developing lungs who is starting vaping and hasn't tried cigarettes yet. 464 00:35:33,693 --> 00:35:39,093 Michael Cox: They're two very different usage cases and two very different sort of outcomes probably as well. 465 00:35:39,353 --> 00:35:45,753 Sheena Fraser: That's smoking, vaping, pollution. What about volatile organic compounds? 466 00:35:46,033 --> 00:35:48,033 Sheena Fraser: Have you come up with that? Have you used much Vox? 467 00:35:48,033 --> 00:35:55,573 Michael Cox: I mean, so not in the context of the lung microbiome very much, to be honest. 468 00:35:56,733 --> 00:36:03,533 Michael Cox: I think what we're often talking about with these things is lung inflammation. 469 00:36:03,873 --> 00:36:09,653 Michael Cox: And that's going to be key for understanding the interaction with the microbiome. 470 00:36:09,653 --> 00:36:17,613 Michael Cox: Because I think one thing, we're always looking at chicken and egg with a gut 471 00:36:17,613 --> 00:36:23,073 Michael Cox: microbiome, with lung microbiome as well. What's causal? 472 00:36:23,653 --> 00:36:32,033 Michael Cox: And we know that there's some pathogens that you can spread around and they 473 00:36:32,033 --> 00:36:36,433 Michael Cox: will infect you and they will cause inflammation. They'll cause infection, 474 00:36:36,633 --> 00:36:37,353 Michael Cox: they'll cause inflammation. 475 00:36:38,473 --> 00:36:43,013 Michael Cox: So, you know, there's examples of viruses like that. There's examples of bacteria 476 00:36:43,013 --> 00:36:45,913 Michael Cox: like that. So one of the streptococci is streptococcus pneumoniae. 477 00:36:46,113 --> 00:36:48,673 Michael Cox: We can carry it, but also it can cause pneumonia. 478 00:36:50,358 --> 00:36:56,418 Michael Cox: However, there are other situations where we might have some kind of inflammation 479 00:36:56,418 --> 00:37:01,478 Michael Cox: caused by something else, whether that's external, like pollution, 480 00:37:01,738 --> 00:37:03,438 Michael Cox: volatile organic compounds or whatever. 481 00:37:03,798 --> 00:37:09,318 Michael Cox: And then the bacteria already in your lungs are in a different environment to 482 00:37:09,318 --> 00:37:10,198 Michael Cox: what they were in before. 483 00:37:10,198 --> 00:37:15,518 Michael Cox: So we see some of the shifts in communities that we see in microbiome studies 484 00:37:15,518 --> 00:37:20,438 Michael Cox: might just simply be a population of bacteria who are having to live now in 485 00:37:20,438 --> 00:37:21,878 Michael Cox: a much more inflammatory environment. 486 00:37:21,878 --> 00:37:25,838 Michael Cox: So they're dealing with a lot more immune system than they're used to dealing 487 00:37:25,838 --> 00:37:27,578 Michael Cox: with on your average day. 488 00:37:27,778 --> 00:37:34,018 Michael Cox: So their response might be to just disappear and die, or it might be to become 489 00:37:34,018 --> 00:37:36,778 Michael Cox: more actively pro-inflammatory as well. 490 00:37:36,778 --> 00:37:42,478 Michael Cox: So anything I think that causes inflammations in the lungs is going to have 491 00:37:42,478 --> 00:37:44,758 Michael Cox: an impact on your respiratory microbiome. 492 00:37:45,538 --> 00:37:50,778 Michael Cox: Whether those changes are then part of the pathology of what then happens afterwards... 493 00:37:52,444 --> 00:37:59,464 Michael Cox: It's hard to say. So volatile organic compounds, particularly bad for lungs. 494 00:37:59,664 --> 00:38:02,624 Michael Cox: It's probably not a good thing to be inhaling all the time. 495 00:38:03,484 --> 00:38:05,584 Sheena Fraser: We should probably say what they are, actually. 496 00:38:05,744 --> 00:38:08,184 Michael Cox: Go for it. There's a bunch of, there's all sorts of different things. 497 00:38:08,284 --> 00:38:10,744 Michael Cox: It's a huge category of chemical compounds. 498 00:38:11,004 --> 00:38:14,644 Sheena Fraser: So they're chemicals that vaporize at room temperature. 499 00:38:14,964 --> 00:38:21,824 Sheena Fraser: So the sort of things that contain your Vox are your spray deodorants and your spray cleaning. 500 00:38:21,824 --> 00:38:27,384 Sheena Fraser: Products, furniture, floor polishes, oven cleaners, detergents, 501 00:38:27,524 --> 00:38:30,244 Sheena Fraser: dishwashers, dishwashing liquids. 502 00:38:31,684 --> 00:38:35,084 Sheena Fraser: And these compounds, as you say, they're totally variable. 503 00:38:35,404 --> 00:38:39,944 Sheena Fraser: And they've studied, there have been some studies on hairdressers that use more. 504 00:38:40,204 --> 00:38:45,624 Sheena Fraser: So, for example, hairdressers that deal with Afro hair more, 505 00:38:45,844 --> 00:38:50,604 Sheena Fraser: they use more of these compounds to straighten the hair. 506 00:38:51,393 --> 00:38:56,713 Sheena Fraser: And they did have a difference in their lung microbiome, presumably through 507 00:38:56,713 --> 00:39:04,273 Sheena Fraser: sputum samples, than the hairdressers that didn't use quite so many of those compounds. 508 00:39:06,193 --> 00:39:13,853 Sheena Fraser: And I think VOX's or exposure to VOX have been linked to lung cancer that I'm 509 00:39:13,853 --> 00:39:16,713 Sheena Fraser: aware of. And there's actually, there's a few studies on that now. 510 00:39:17,113 --> 00:39:22,193 Sheena Fraser: And women especially seem to be more vulnerable to the effect of Vox on the lungs. 511 00:39:22,373 --> 00:39:27,893 Sheena Fraser: From a study, there was a study that was written in 2018, Long-Term Effects 512 00:39:27,893 --> 00:39:29,233 Sheena Fraser: of Cleaning on the Lungs. 513 00:39:30,333 --> 00:39:36,493 Sheena Fraser: And it looked at a whole bunch of 6,000 adults between 1992 and 1994. 514 00:39:37,033 --> 00:39:42,673 Sheena Fraser: And they looked at people who clean for a living and people who clean domestically. 515 00:39:42,673 --> 00:39:51,333 Sheena Fraser: And women especially who clean for a living had a lot more disruption to their 516 00:39:51,333 --> 00:39:53,593 Sheena Fraser: microbiome and they looked at levels of inflammation. 517 00:39:54,153 --> 00:39:58,353 Sheena Fraser: I think they're measuring FENO, is that right? 518 00:39:58,593 --> 00:40:04,233 Michael Cox: Oh yes, I've heard of that one. So this is the thing, so I'm not a sort of respiratory 519 00:40:04,233 --> 00:40:11,513 Michael Cox: doctor And so this sort of heads into the realm of occupational exposure and 520 00:40:11,513 --> 00:40:13,153 Michael Cox: those kind of respiratory diseases. 521 00:40:13,253 --> 00:40:17,073 Michael Cox: So they're often also less well studied 522 00:40:17,073 --> 00:40:22,013 Michael Cox: than, you know, either the chronic infective kind of lung diseases. 523 00:40:22,233 --> 00:40:27,013 Michael Cox: So these sort of exposure diseases, because maybe they, you know, 524 00:40:27,453 --> 00:40:32,353 Michael Cox: they're harder to spot. So hairdressers, for example, you know, 525 00:40:32,453 --> 00:40:34,753 Michael Cox: it's a more dispersed group of people. 526 00:40:34,893 --> 00:40:41,453 Michael Cox: They're not working for one organization and trying to even noticing that they 527 00:40:41,453 --> 00:40:46,673 Michael Cox: have particular sort of impacts on their respiratory health is hard work. 528 00:40:47,446 --> 00:40:52,406 Sheena Fraser: In this world that we're living in we're obviously surrounded by these chemicals 529 00:40:52,406 --> 00:40:56,946 Sheena Fraser: aren't we it's very hard to avoid them they're they're in our lives in you know 530 00:40:56,946 --> 00:41:02,626 Sheena Fraser: in so many different ways so so it would be good to get more research into this i think. 531 00:41:02,626 --> 00:41:03,426 Michael Cox: So yeah for. 532 00:41:03,426 --> 00:41:10,786 Sheena Fraser: Sure and to get more understanding of you know the harms from these things because 533 00:41:10,786 --> 00:41:16,506 Sheena Fraser: you know we need to know if we are doing ourselves harms with our once-a-week clean, 534 00:41:16,546 --> 00:41:22,906 Sheena Fraser: or if we should be switching to less harmful things, 535 00:41:23,086 --> 00:41:28,966 Sheena Fraser: and liquid preparations rather than spray preparations, what's the risk? 536 00:41:28,986 --> 00:41:33,266 Sheena Fraser: If we're using deodorant, should we use liquid or solid deodorant, or should we use spray? 537 00:41:33,266 --> 00:41:34,326 Michael Cox: Should we be rolling on? 538 00:41:36,486 --> 00:41:41,086 Sheena Fraser: And so I do worry about the impact of these chemicals on the lungs, 539 00:41:41,106 --> 00:41:45,986 Sheena Fraser: and it makes a lot lot of sense from the reading I've done into aluminium and 540 00:41:45,986 --> 00:41:51,146 Sheena Fraser: into various different chemicals that are in these products that it would be 541 00:41:51,146 --> 00:41:52,706 Sheena Fraser: creating inflammation there. 542 00:41:53,786 --> 00:41:58,826 Sheena Fraser: So I think this would be, you know, good to know a little bit more about. 543 00:41:59,106 --> 00:42:02,386 Sheena Fraser: So let me know if you know anybody that's investigating books, 544 00:42:02,386 --> 00:42:05,666 Sheena Fraser: because, you know, you're the guy who's going to find out. 545 00:42:05,906 --> 00:42:08,506 Michael Cox: I think the interesting thing there around microbiome, though, 546 00:42:08,606 --> 00:42:11,066 Michael Cox: is like, what would the solution be? 547 00:42:11,306 --> 00:42:16,666 Michael Cox: Is that a microbiome solution that we would be coming up with for that kind of thing? 548 00:42:16,866 --> 00:42:24,546 Michael Cox: But actually, you know, it's the solution there would be changing the way we 549 00:42:24,546 --> 00:42:29,946 Michael Cox: clean, changing the cleaning products, not a sort of microbiome intervention. 550 00:42:30,266 --> 00:42:34,566 Michael Cox: Maybe the microbiome is playing a part, but actually the solution there is probably 551 00:42:34,566 --> 00:42:38,146 Michael Cox: not a microbiome-based solution. And that's interesting across the field, 552 00:42:38,186 --> 00:42:40,606 Michael Cox: I think, as well, because you see... 553 00:42:41,108 --> 00:42:45,368 Michael Cox: You see some people suggesting sometimes interventions that are microbiome-based, 554 00:42:45,528 --> 00:42:49,148 Michael Cox: but for things that actually we can impact in different ways. 555 00:42:49,448 --> 00:42:54,648 Michael Cox: And I'm in favor of choosing the right intervention there. 556 00:42:54,888 --> 00:43:01,548 Michael Cox: So dietary stuff, for example, sometimes people reach for a probiotic or a live biotherapeutic. 557 00:43:01,648 --> 00:43:06,548 Michael Cox: And you're like, well, maybe, have we tested this against eating a banana once a day? 558 00:43:06,548 --> 00:43:13,348 Michael Cox: You know, improving your fiber intake or doing the sort of boring kind of five-a-day 559 00:43:13,348 --> 00:43:18,388 Michael Cox: interventions rather than necessarily going straight to a probiotic as your 560 00:43:18,388 --> 00:43:21,648 Michael Cox: first line of things to do. 561 00:43:22,208 --> 00:43:26,008 Sheena Fraser: Okay, well, you're moving on to diet now. So that was one of my next things. 562 00:43:27,108 --> 00:43:30,728 Sheena Fraser: How does diet influence your lung microbiome? 563 00:43:30,728 --> 00:43:37,108 Michael Cox: I have lovely occasional arguments. So we have a really famous microbiome researcher 564 00:43:37,108 --> 00:43:38,668 Michael Cox: at Birmingham, Professor Lindsay Hall. 565 00:43:38,868 --> 00:43:41,468 Michael Cox: So she works on the infant gut microbiome. 566 00:43:41,728 --> 00:43:48,928 Michael Cox: And obviously, and particularly sort of mother and baby pairs and preterm birth 567 00:43:48,928 --> 00:43:52,368 Michael Cox: and things like that and how that relates to particularly bifida bacteria. 568 00:43:53,328 --> 00:44:00,968 Michael Cox: But we have a semi-regular conversation about dietary impact on the lung microbiome. 569 00:44:01,048 --> 00:44:03,708 Michael Cox: And she's like, yes, of course, there's going to be a massive impact. 570 00:44:04,048 --> 00:44:05,928 Michael Cox: And I'm like, no, there definitely won't be. 571 00:44:06,788 --> 00:44:10,768 Michael Cox: And probably the reality is somewhere between the two of those things. 572 00:44:11,108 --> 00:44:18,308 Michael Cox: So I think the thing to remember is timescale and location of stuff. 573 00:44:18,668 --> 00:44:21,208 Michael Cox: So diet can have systemic effect. 574 00:44:22,589 --> 00:44:29,909 Michael Cox: But the important part of the interaction with the lung is that there are microorganisms 575 00:44:29,909 --> 00:44:32,369 Michael Cox: right there next to those cells. 576 00:44:33,789 --> 00:44:38,069 Michael Cox: And we're always thinking, so gut microbiome focus, it influences the whole body. 577 00:44:38,249 --> 00:44:43,649 Michael Cox: It's like, yes, but these organisms are right there next to these immune cells, 578 00:44:43,869 --> 00:44:48,169 Michael Cox: being sampled by these immune cells, interacting directly with the epithelium. 579 00:44:48,509 --> 00:44:52,969 Michael Cox: Gut microbiome is further away. It's in a different compartment. 580 00:44:53,109 --> 00:44:56,889 Michael Cox: It's a different composition. So to have an impact there, 581 00:44:57,229 --> 00:45:02,409 Michael Cox: those organisms have to be churning out stuff that goes through a lot of filtering 582 00:45:02,409 --> 00:45:08,749 Michael Cox: into the bloodstream around the body, then it's a more distal effect. 583 00:45:08,749 --> 00:45:13,049 Michael Cox: So what we're looking at there really is time, I think. 584 00:45:13,289 --> 00:45:19,369 Michael Cox: So in shorter timescales, in the timescales of sort of catching an infection, 585 00:45:19,849 --> 00:45:24,169 Michael Cox: being exposed to some pollution or something like that, local processes are 586 00:45:24,169 --> 00:45:25,249 Michael Cox: going to be super important. 587 00:45:25,649 --> 00:45:33,529 Michael Cox: The timescale of sort of a life or years or those kinds of things, 588 00:45:33,789 --> 00:45:37,489 Michael Cox: over the period of time where you might affect a change in your diet. 589 00:45:38,778 --> 00:45:41,658 Michael Cox: Then probably that is going to have some sort of 590 00:45:41,658 --> 00:45:44,838 Michael Cox: systemic impact as well so so she and 591 00:45:44,838 --> 00:45:47,898 Michael Cox: i sort of have this conversation regularly and i 592 00:45:47,898 --> 00:45:50,978 Michael Cox: think it i think really what we're talking about is time 593 00:45:50,978 --> 00:45:53,918 Michael Cox: scale there so if you change your diet probably the 594 00:45:53,918 --> 00:45:58,558 Michael Cox: impact is not going to be anything immediate um if you change your diet in such 595 00:45:58,558 --> 00:46:04,478 Michael Cox: a way that um you change your weight you change your lifestyle then maybe longer 596 00:46:04,478 --> 00:46:08,278 Michael Cox: term we will see those things those studies haven't been done because they're 597 00:46:08,278 --> 00:46:11,478 Michael Cox: hard to do in the gut let alone they. 598 00:46:11,478 --> 00:46:15,458 Sheena Fraser: Tend to be epidemiological so they tend to be looking at again correlations 599 00:46:15,458 --> 00:46:20,998 Sheena Fraser: don't they so the so people that eat more than five a day of fruits and vegetables um. 600 00:46:20,998 --> 00:46:23,958 Michael Cox: Well done then yeah tend to have lower. 601 00:46:23,958 --> 00:46:26,798 Sheena Fraser: They tend to have lower rates of asthma for. 602 00:46:26,798 --> 00:46:29,198 Michael Cox: Example or crpd yeah um. 603 00:46:29,198 --> 00:46:34,198 Sheena Fraser: And i you know i i've always thought that it did play a role um And personally, 604 00:46:34,418 --> 00:46:39,278 Sheena Fraser: because I had two grandmothers who smoked for 50 years, neither of which got COPD. 605 00:46:39,718 --> 00:46:46,818 Sheena Fraser: And they had a lot of plants in their diet. And okay, they did enough exercise and things as well. 606 00:46:46,898 --> 00:46:49,918 Sheena Fraser: But I often thought that their lifestyle played a role in that. 607 00:46:50,798 --> 00:46:56,078 Sheena Fraser: And that is very anecdotal. But I've actually used that process with patients 608 00:46:56,078 --> 00:46:58,058 Sheena Fraser: and got them on higher fiber diets. 609 00:46:58,218 --> 00:47:02,678 Sheena Fraser: And what I've noticed is my COPD patients have particularly low fiber diets. 610 00:47:03,138 --> 00:47:06,438 Sheena Fraser: When they're diagnosed. And I put them on a much higher fiber diet. 611 00:47:06,458 --> 00:47:12,558 Sheena Fraser: And the last chat that I did, you know, we don't have a lot of COPDs in our 612 00:47:12,558 --> 00:47:15,118 Sheena Fraser: practice, but we had a guy who had quite severe COPD. 613 00:47:15,918 --> 00:47:17,358 Sheena Fraser: This was about eight years ago. 614 00:47:18,083 --> 00:47:23,403 Sheena Fraser: And, um, he, he came to me and he had a low fiber diet, not doing very much exercise. 615 00:47:23,743 --> 00:47:28,783 Sheena Fraser: And I got him to adopt a high fiber diet and exercise really, really regularly. 616 00:47:29,463 --> 00:47:33,443 Sheena Fraser: So it's, you know, it's a cumulative, it's, it's a few different things that were changing. 617 00:47:33,843 --> 00:47:38,383 Sheena Fraser: Um, but in that time, since in that eight years, instead of nose diving, 618 00:47:38,563 --> 00:47:43,183 Sheena Fraser: like most of my COPD patients had done in the past, um, he's actually remained 619 00:47:43,183 --> 00:47:48,423 Sheena Fraser: incredibly well and fit and had one infection in that time that I'm aware of. 620 00:47:49,443 --> 00:47:55,283 Sheena Fraser: So he's remained very, very fit and healthy and not got the number of infections 621 00:47:55,283 --> 00:48:00,603 Sheena Fraser: that I was expecting that he would get compared to other COPD patients. 622 00:48:00,763 --> 00:48:04,743 Sheena Fraser: And the other thing, the other little bit of evidence that I see as a doctor 623 00:48:04,743 --> 00:48:07,983 Sheena Fraser: is the oral microgram and the importance. 624 00:48:08,163 --> 00:48:12,983 Sheena Fraser: So whilst you say that diet is going to have that sort of slightly longer effect, 625 00:48:13,283 --> 00:48:16,643 Sheena Fraser: you know, it's going to take longer for it to impact coming from the gut. 626 00:48:16,963 --> 00:48:20,283 Sheena Fraser: The oral microbiome is going to change quite rapidly with diet change, 627 00:48:20,403 --> 00:48:23,743 Sheena Fraser: isn't it? And the oral microbiome is going to impact on the lung. 628 00:48:23,763 --> 00:48:24,143 Sheena Fraser: It's the source of organisms. 629 00:48:24,583 --> 00:48:30,403 Michael Cox: Yeah, 100%. It's super, it's so difficult and it's really interesting because... 630 00:48:31,671 --> 00:48:37,451 Michael Cox: It's so hard in a human to make one change because you're always, 631 00:48:37,751 --> 00:48:42,991 Michael Cox: you know, so if somebody's improving their diet, then maybe they're feeling a bit better. 632 00:48:43,131 --> 00:48:48,651 Michael Cox: They get out a bit more and then exercise becomes an impact or even it turns 633 00:48:48,651 --> 00:48:52,431 Michael Cox: out that they start running in a field and they're getting a lot more hay fever 634 00:48:52,431 --> 00:48:55,291 Michael Cox: and it goes in the other way or, you know, all this kind of stuff. 635 00:48:55,291 --> 00:48:58,051 Michael Cox: Oral microbiome for sure is linked to 636 00:48:58,051 --> 00:49:01,311 Michael Cox: things like copd so um you 637 00:49:01,311 --> 00:49:05,111 Michael Cox: know improved uh dental care 638 00:49:05,111 --> 00:49:09,331 Michael Cox: um you've got fewer less 639 00:49:09,331 --> 00:49:12,871 Michael Cox: plaque less uh organisms like 640 00:49:12,871 --> 00:49:15,691 Michael Cox: that sort of heading down into your lungs so there does seem 641 00:49:15,691 --> 00:49:19,011 Michael Cox: to be a relationship there um the the 642 00:49:19,011 --> 00:49:21,831 Michael Cox: cardiac doctors will probably say don't brush your 643 00:49:21,831 --> 00:49:25,111 Michael Cox: teeth too much because there's another link between 644 00:49:25,111 --> 00:49:28,571 Michael Cox: sort of endocarditis and and sort 645 00:49:28,571 --> 00:49:31,431 Michael Cox: of heart health and brushing your 646 00:49:31,431 --> 00:49:36,191 Michael Cox: teeth too much or doing too much flossing and removing this stuff which goes 647 00:49:36,191 --> 00:49:40,911 Michael Cox: into your body and bloodstream and can link to link to heart disease in that 648 00:49:40,911 --> 00:49:45,391 Michael Cox: way so yeah it's super complicated particularly when we start talking about 649 00:49:45,391 --> 00:49:49,931 Michael Cox: a human and their life but but you know. 650 00:49:50,750 --> 00:49:57,050 Sheena Fraser: And I do wonder if those lactobacilli and nice milk-fermented foods and things 651 00:49:57,050 --> 00:50:02,290 Sheena Fraser: are going to also benefit the lungs just through the effect on the immune system. 652 00:50:04,630 --> 00:50:10,230 Michael Cox: It is funny. So lactobacilli is sort of falling out of favor in the gut space as well. 653 00:50:10,510 --> 00:50:18,590 Michael Cox: So people like the bifida bacteria are what people are sort of going after. 654 00:50:18,590 --> 00:50:20,430 Michael Cox: But there's trends around this. 655 00:50:20,750 --> 00:50:24,110 Michael Cox: At the moment, we don't even know whether the ones that you find in the lungs 656 00:50:24,110 --> 00:50:27,490 Michael Cox: are the same species as the ones that we have in the guts. 657 00:50:28,430 --> 00:50:34,450 Michael Cox: So, again, at the moment, we're talking about a distal effect of those lactobacilli, 658 00:50:34,730 --> 00:50:36,550 Michael Cox: even if there is one at all. 659 00:50:38,110 --> 00:50:45,270 Michael Cox: And trials of probiotics are sort of fraught with as many more failures than 660 00:50:45,270 --> 00:50:46,630 Michael Cox: there are sort of success stories. 661 00:50:47,550 --> 00:50:52,250 Michael Cox: It would be lovely to see some interventions in the long space that, 662 00:50:53,226 --> 00:50:58,586 Michael Cox: acknowledge the existence of a lung microbiome to start with and then maybe 663 00:50:58,586 --> 00:51:05,106 Michael Cox: start to utilize it as a real tool for helping us with our health. 664 00:51:05,406 --> 00:51:11,426 Michael Cox: I think that's where I'd like to see things go, but at the moment we're quite far off that. 665 00:51:11,706 --> 00:51:17,486 Sheena Fraser: Well, as microbiome medics, we don't push people towards probiotics very often, 666 00:51:17,666 --> 00:51:21,926 Sheena Fraser: but we would push people towards a nice, healthy diet with fermented foods. 667 00:51:22,106 --> 00:51:24,146 Michael Cox: It's the banana. I think it's the banana. 668 00:51:24,406 --> 00:51:29,546 Sheena Fraser: Fermented foods regularly. And the Sonnenbergs in the US have really shown the 669 00:51:29,546 --> 00:51:33,006 Sheena Fraser: impact of fermented foods on the gut and how beneficial that is. 670 00:51:33,266 --> 00:51:38,526 Sheena Fraser: So we haven't touched on exercise in the lungs. And I think that's a really important area. 671 00:51:39,586 --> 00:51:42,546 Sheena Fraser: So tell me about exercise in the lungs. 672 00:51:43,026 --> 00:51:48,506 Michael Cox: So it's not something, I think, again, I'm sort of thinking mostly about a sort of proxy here, 673 00:51:48,506 --> 00:51:55,326 Michael Cox: which is respiratory physiotherapy and shifting stuff up and out of the lungs 674 00:51:55,326 --> 00:51:58,386 Michael Cox: if you have a lung disease. 675 00:51:59,106 --> 00:52:03,346 Michael Cox: Certainly that's been shown to have a really positive impact in cystic fibrosis. 676 00:52:04,286 --> 00:52:09,766 Michael Cox: And it's part of normal therapy there for people with cystic fibrosis. 677 00:52:10,806 --> 00:52:17,346 Michael Cox: If you can improve your sort of lung health in general, and exercise is one 678 00:52:17,346 --> 00:52:20,726 Michael Cox: way to do that, then probably it's going to help, 679 00:52:22,887 --> 00:52:26,527 Michael Cox: Prevention is a really strong word, but certainly improving your risk, 680 00:52:26,787 --> 00:52:29,487 Michael Cox: I think. Again, we'll probably see that at the population level. 681 00:52:30,187 --> 00:52:34,767 Michael Cox: Really hard to say what it's doing at an individual level mechanistically in 682 00:52:34,767 --> 00:52:35,667 Michael Cox: terms of lung microbiome. 683 00:52:35,767 --> 00:52:40,807 Michael Cox: But I think numbers, you know, fewer numbers, if you've got an increase compared 684 00:52:40,807 --> 00:52:42,967 Michael Cox: to normal, is probably a good thing. 685 00:52:43,347 --> 00:52:48,227 Sheena Fraser: Yeah, as you say, there's probably so many different mechanisms by which exercise benefits. 686 00:52:48,947 --> 00:52:54,087 Sheena Fraser: Microbes yeah um and you know it depends whether you're exercising in nature 687 00:52:54,087 --> 00:52:58,567 Sheena Fraser: or exercising uh you know in a gym environment again you're going to pick up 688 00:52:58,567 --> 00:53:02,467 Sheena Fraser: different microbes and things aren't you and yeah and you're going to have different 689 00:53:02,467 --> 00:53:05,747 Sheena Fraser: impacts from fresh air and and you know if there's. 690 00:53:05,747 --> 00:53:10,047 Michael Cox: Somebody in the corner who's who's you know who's who happens to have rsv or 691 00:53:10,047 --> 00:53:14,187 Michael Cox: covid at that particular time then you know that's going to outweigh your your 692 00:53:14,187 --> 00:53:19,987 Michael Cox: the impact of your uh of your uh of your particular exercise regimen on that. 693 00:53:19,987 --> 00:53:24,927 Sheena Fraser: Day yeah but hopefully if you're exercising hard then you know hopefully you're 694 00:53:24,927 --> 00:53:29,647 Sheena Fraser: stimulating your immune system enough to to be able to tackle those those viruses 695 00:53:29,647 --> 00:53:33,927 Sheena Fraser: that are probably in the air all the time anyway yeah yeah yeah, 696 00:53:36,006 --> 00:53:39,246 Sheena Fraser: um okay so so exercise 697 00:53:39,246 --> 00:53:42,586 Sheena Fraser: good and and we know from epidemiological studies 698 00:53:42,586 --> 00:53:45,746 Sheena Fraser: that exercise really helps with um you 699 00:53:45,746 --> 00:53:51,686 Sheena Fraser: know the reducing your likelihood of asthma COPDs all these all these long chronic 700 00:53:51,686 --> 00:53:56,626 Sheena Fraser: lung conditions and and of course helping reduce your chance of more serious 701 00:53:56,626 --> 00:54:02,966 Sheena Fraser: lung conditions like um lung cancer yeah so so they're all beneficial but there's there I. 702 00:54:02,966 --> 00:54:06,266 Michael Cox: Think we have to remember there, sorry to interrupt, we do have to remember 703 00:54:06,266 --> 00:54:08,966 Michael Cox: there the genetic components to these diseases as well. 704 00:54:10,266 --> 00:54:16,386 Michael Cox: Because sometimes I think we sort of encourage groups of people to do things, 705 00:54:16,526 --> 00:54:22,406 Michael Cox: but actually it's very hard for them because they have a genetic predisposition to a particular thing. 706 00:54:22,546 --> 00:54:25,626 Michael Cox: So asthma has a genetic component as well as an environmental. 707 00:54:26,846 --> 00:54:31,006 Michael Cox: COPD, there's people with alpha-1 antitripsin. So I'm a carrier of that. 708 00:54:32,346 --> 00:54:36,746 Michael Cox: And that gives you a much higher chance of getting COPD. 709 00:54:37,406 --> 00:54:43,966 Michael Cox: So exercise is a component for sure, but it's only going to take some people so far of the way. 710 00:54:44,246 --> 00:54:50,266 Sheena Fraser: Of course. And some genetic conditions are, your genes are your fate. 711 00:54:50,446 --> 00:54:55,206 Sheena Fraser: With the case of cystic fibrosis, of course, you can't turn that around. 712 00:54:56,166 --> 00:55:02,806 Sheena Fraser: But for a lot of of genetic disorders, genes can flip and genes can change. 713 00:55:02,926 --> 00:55:07,286 Sheena Fraser: And epigenetics is a very interesting thing where, you know, 714 00:55:07,526 --> 00:55:11,166 Sheena Fraser: your lifestyle actually can massively influence your genes and you can turn 715 00:55:11,166 --> 00:55:16,086 Sheena Fraser: on and off genes through, you know, changing your lifestyle quite dramatically. 716 00:55:16,506 --> 00:55:21,866 Sheena Fraser: And, you know, in lifestyle medicine, we learn a lot about epigenetics and how 717 00:55:21,866 --> 00:55:28,666 Sheena Fraser: we can influence our genes through diet and lifestyle and sleep and exercise 718 00:55:28,666 --> 00:55:31,606 Sheena Fraser: and all of these things. So there's hope for... 719 00:55:32,522 --> 00:55:37,882 Sheena Fraser: The majority of us. But of course, you know, if you have a serious genetic disorder, 720 00:55:38,202 --> 00:55:44,482 Sheena Fraser: then unfortunately we can't often flip those genetics for you. 721 00:55:45,042 --> 00:55:50,282 Sheena Fraser: So yes, it depends on the genetic disorder, doesn't it? 722 00:55:50,742 --> 00:55:57,002 Sheena Fraser: Okay. All right. Interesting. So if you have one message, Mike, 723 00:55:57,182 --> 00:56:01,082 Sheena Fraser: before we go about the lung microbiome that you want to get across to people. 724 00:56:01,622 --> 00:56:06,302 Sheena Fraser: You want to spike their interest and obviously get them thinking about the lung 725 00:56:06,302 --> 00:56:07,562 Sheena Fraser: microbiome. What will you say? 726 00:56:09,522 --> 00:56:10,722 Michael Cox: That's a challenge. 727 00:56:13,042 --> 00:56:17,802 Michael Cox: What this always makes me think of is slightly bored students in my lectures. 728 00:56:18,342 --> 00:56:20,922 Michael Cox: And I think, so how do we get them engaged? 729 00:56:22,462 --> 00:56:27,082 Michael Cox: I think the thing with the lung microbiome is that it is real. 730 00:56:27,082 --> 00:56:32,402 Michael Cox: It's changes with disease and we really need to understand it because there's 731 00:56:32,402 --> 00:56:40,922 Michael Cox: real potential there to have some kind of intervention that makes conditions last less time. 732 00:56:41,202 --> 00:56:48,262 Michael Cox: I would hope that actually we get some ways of predicting when we need to intervene 733 00:56:48,262 --> 00:56:52,122 Michael Cox: through understanding the lung microbiome. That's where I'd really like to go, I think. 734 00:56:53,522 --> 00:56:58,642 Michael Cox: So some sort of meaningful intervention and also understanding what interventions 735 00:56:58,642 --> 00:57:01,782 Michael Cox: aren't worthwhile as well because again, 736 00:57:02,042 --> 00:57:09,782 Michael Cox: you know, interfering too much can be an issue too so that's what I'm interested 737 00:57:09,782 --> 00:57:16,582 Michael Cox: in in particular I think in this space and I'm hoping my sheer enthusiasm will 738 00:57:16,582 --> 00:57:19,962 Michael Cox: carry other people along with me because I'm not sure whether the message does or not. 739 00:57:20,932 --> 00:57:25,392 Sheena Fraser: Well, do you know, the interest in microbiomes, human microbiomes in general, 740 00:57:25,612 --> 00:57:27,432 Sheena Fraser: is just climbing constantly. 741 00:57:27,952 --> 00:57:34,132 Sheena Fraser: You know, I'm just, you know, I'm even seeing it in my primary and secondary care colleagues now, 742 00:57:34,272 --> 00:57:39,192 Sheena Fraser: that more and more of them are taking note of microbiome science and want to 743 00:57:39,192 --> 00:57:43,352 Sheena Fraser: learn about the gut microbiome and other human microbiomes. 744 00:57:43,352 --> 00:57:48,472 Sheena Fraser: So, you know, I think the interest is starting to peak now and we just need 745 00:57:48,472 --> 00:57:52,172 Sheena Fraser: to keep people's enthusiasm up and hopefully, 746 00:57:52,572 --> 00:57:56,532 Sheena Fraser: you know, more interest, you know, instead of just thinking of the lungs in 747 00:57:56,532 --> 00:58:01,592 Sheena Fraser: terms of physiology and, you know, in terms of the diseases of the lungs. 748 00:58:01,592 --> 00:58:09,112 Sheena Fraser: Let's think a little bit more deeply and consider the microbes as well and think 749 00:58:09,112 --> 00:58:14,352 Sheena Fraser: about them and how there's this other element here that could be changing the 750 00:58:14,352 --> 00:58:17,552 Sheena Fraser: dynamics of this important organ. 751 00:58:18,192 --> 00:58:23,532 Sheena Fraser: And we all should be aware of these little organisms and how they're impacting our health. 752 00:58:23,632 --> 00:58:27,212 Sheena Fraser: And we need to learn more, as you say, as to why that is. 753 00:58:27,552 --> 00:58:30,212 Sheena Fraser: So thank you so much for coming on today. 754 00:58:31,412 --> 00:58:34,872 Sheena Fraser: Good luck with all your research what's next for you Mike? 755 00:58:35,312 --> 00:58:40,432 Michael Cox: I think we're trying to understand what the bacteria in our lungs are eating 756 00:58:40,432 --> 00:58:44,852 Michael Cox: because they've got to eat something and then we can tweak that and then we've 757 00:58:44,852 --> 00:58:50,352 Michael Cox: got a little tool to manipulate the communities so that's one of the next things 758 00:58:50,352 --> 00:58:51,712 Michael Cox: we're looking at Brilliant. 759 00:58:51,852 --> 00:58:57,892 Sheena Fraser: Right well keep me informed keep me updated Take care, nice to see you Bye bye. 760 00:59:02,552 --> 00:59:06,072 Intro and Outro: Thank you so much for listening to this episode of Microbiomedics Podcast. 761 00:59:06,652 --> 00:59:09,992 Intro and Outro: We really hope you enjoy the content and we welcome your feedback. 762 00:59:10,512 --> 00:59:13,772 Intro and Outro: We'd love to hear any suggestions you might have for microbiome topics that 763 00:59:13,772 --> 00:59:17,632 Intro and Outro: you'd like us to cover and we also appreciate listeners' questions and we'll 764 00:59:17,632 --> 00:59:19,392 Intro and Outro: endeavour to answer them in the next podcast.